BioTuesdays

Tag - Dae Gon Ha

Surrozen

Stifel starts Surrozen at buy; PT $19

Stifel launched coverage of Surrozen (NASDAQ:SRZN) with a “buy” rating and $19 target price. The stock closed at $7.24 on Sept. 3. Surrozen discovers and develops biologic drug candidates to selectively modulate the Wnt...

chemocentryx

Stifel ups ChemoCentryx to buy; PT $31

Stifel upgraded ChemoCentryx (NASDAQ:CCXI) to “buy” from “hold” and raised its price target to $31 from $26, citing a more favorable risk/reward for avacopan heading into a new PDUFA date. The stock closed at $14.05 on...

ProQR

Stifel starts ProQR Therapeutics at buy; PT $20

Stifel initiated coverage of ProQR Therapeutics N.V. (NASDAQ:PRQP) with a “buy” rating and price target of $20. The stock finished at $6.22 on April 30. “As a clinical-stage company with demonstrated proof-of-concept...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.